Interestingly, both curcumin [61] and metformin, an anti-diabetic drug [62], were found to inhibit EMT by blocking the IL-6/STAT3 axis–curcumin in hepatocellular carcinoma [61] and metformin in lung cancer [62]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.